{
    "id": 25647,
    "fullName": "MYH9 - ALK",
    "impact": "fusion",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "MYH9-ALK results from the fusion of MYH9 and ALK, which demonstrates constitutive expression of the fusion transcript, cytoplasmic-restricted ALK staining, and tyrosine phosphorylation of the fusion protein in vivo, but lack of kinase activity in vitro (PMID: 12800156), and therefore, the effect on protein function is unknown. MYH9-ALK fusions have been identified in anaplastic large cell lymphoma (PMID: 12800156).",
            "references": [
                {
                    "id": 6864,
                    "pubMedId": 12800156,
                    "title": "Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/12800156"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4627,
        "geneSymbol": "MYH9",
        "terms": [
            "MYH9",
            "BDPLT6",
            "DFNA17",
            "EPSTS",
            "FTNS",
            "MATINS",
            "MHA",
            "NMHC-II-A",
            "NMMHC-IIA",
            "NMMHCA"
        ]
    },
    "variant": "MYH9 - ALK",
    "createDate": "10/25/2016",
    "updateDate": "10/31/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 238,
                "geneSymbol": "ALK",
                "terms": [
                    "ALK",
                    "CD246",
                    "NBLST3"
                ]
            }
        }
    ],
    "evidence": [
        
    ],
    "molecularProfiles": [
        {
            "id": 26708,
            "profileName": "MYH9 - ALK",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}